EIC USA Soft-landing programme for Health and Life Sciences

The EIC USA Soft-landing Programme is a new exclusive EIC acceleration service created with the objective of supporting the EIC scaleup companies looking to grow and scale in the USA market with the assistance of established local partners.

About : 
The European Innovation Council (EIC) invites EIC companies working in health and life sciences to apply to the curated EIC Soft-landing programme to scale their business in USA with the support of the most prestigious local business partners.
This service is free of charge for EIC beneficiaries and includes six weeks of pre-departure preparation followed by one immersion week in San Francisco and Silicon Valley from the 19th to 24th May 2024.
15 EIC companies selected will enjoy the support of high-level local domain experts, access to dedicated pitching and networking activities, targeted market insights and warm introductions to the most relevant stakeholders within the San Francisco/Silicon Valley ecosystem including high level investors, corporates and innovation hubs.

If you are in the health and life sciences sector and are interested in accelerating your business in the USA:

Apply here NOW!  

Application deadline: 25 March 2024

For this first edition of the EIC USA Soft-landing programme, the EIC will count on the special guidance and support of EIC ambassador, experienced investor and entrepreneur, Jillian Manus, and the partnering with some of the most prestigious actors in the area:

  • Stanford School of Medicine in Palo Alto.
  • INSEAD San Francisco Hub.
  • Nasdaq Entrepreneurial Center San Francisco.
  • San Francisco Bay Area Council.

Who can apply?
EIC-funded companies working on innovative advancements in the following fields:

  • Biomanufacturing
  • Biotechnology
  • Brain Health
  • Cell and Gene Therapies/Genome Editing
  • Chronic Diseases
  • Clinical Trials
  • Diagnostics and Personalized Medicine
  • Digital Health
  • Next Generation Biotherapeutics
  • Oncology
  • Patient Advocacy
  • Rare Diseases

Selection criteria
You will be assessed on your potential for the USA market. Expect to provide information on:

  • Your plan to enter the USA market.
  • The expected impact of your participation in the USA Soft-landing.
  • The fit of your innovative products and services with the USA market needs.
  • Your commitment of financial and human resources to participate in the US Soft-landing.
  • Your contribution to EU strategic autonomy as technology powerhouse.

Please note that you are required to submit a 4-slide pitch deck as part of your application (see instructions in the online application form). The information you provide will be shared with external experts to maximise potential benefits and the impact of your participation.

Shortlisted applicants will undergo a final interview with the selection committee, which will include a member of the investment team.

This acceleration service is free of charge for selected EIC awardees. Please note that participating EIC awardees must cover their own costs for travel and accommodation.




anorexia covid19 design event evento Fabio De Furia florida Genius health lazio medicine miami miami dade miamisic nanotechnology PMI research small industry startups